New Owner
ELAN BioPharmaceuticals - Omega Pharma NV
ELAN BioPharmaceuticals acquires Omega Pharma NV
Announced: November 06, 2014
Type: Acquisition
Disposition: Subsidiary
Status: Complete
Amount: $ 4,500,000,000
